MENU
+Compare
HLTRF
Stock ticker: OTC
AS OF
Aug 27 closing price
Price
$3.80
Change
-$0.00 (-0.00%)
Capitalization
124.03M

HLTRF HLS Therapeutics Inc. Forecast, Technical & Fundamental Analysis

HLS Therapeutics Inc is a specialty pharmaceutical company... Show more

HLTRF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for HLTRF with price predictions
Sep 05, 2025

HLTRF in +1.60% Uptrend, rising for three consecutive days on August 18, 2025

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where HLTRF advanced for three days, in of 18 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Aroon Indicator entered an Uptrend today. In of 154 cases where HLTRF Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 15 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Moving Average Convergence Divergence Histogram (MACD) for HLTRF turned negative on September 02, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 38 similar instances when the indicator turned negative. In of the 38 cases the stock turned lower in the days that followed. This puts the odds of success at .

HLTRF broke above its upper Bollinger Band on August 18, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.792) is normal, around the industry mean (16.681). P/E Ratio (0.000) is within average values for comparable stocks, (74.219). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.902). Dividend Yield (0.013) settles around the average of (0.031) among similar stocks. P/S Ratio (2.139) is also within normal values, averaging (42.934).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. HLTRF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HLTRF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.

View a ticker or compare two or three
HLTRF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published Dividends

HLTRF paid dividends on September 15, 2021

HLS Therapeutics Inc. HLTRF Stock Dividends
А dividend of $0.05 per share was paid with a record date of September 15, 2021, and an ex-dividend date of July 29, 2021. Read more...
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
N/A
Address
10 Carlson Court
Phone
+1 647 495-9000
Employees
90
Web
https://www.hlstherapeutics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FRCOF332.1511.10
+3.46%
Fast Retailing Co. Ltd.
NDRBF4.75N/A
N/A
Nibe Industrier AB
HMTXF0.07N/A
N/A
Hemostemix Inc
FXCXD1.95N/A
N/A
FIH Mobile Ltd
CVVUF0.65-0.01
-1.37%
CanAlaska Uranium Ltd.

HLTRF and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, HLTRF has been loosely correlated with LBTSF. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if HLTRF jumps, then LBTSF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HLTRF
1D Price
Change %
HLTRF100%
N/A
LBTSF - HLTRF
38%
Loosely correlated
N/A
INIS - HLTRF
17%
Poorly correlated
N/A
ETST - HLTRF
12%
Poorly correlated
-0.74%
HKMPF - HLTRF
11%
Poorly correlated
N/A
GTBIF - HLTRF
8%
Poorly correlated
+4.55%
More

Groups containing HLTRF

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HLTRF
1D Price
Change %
HLTRF100%
N/A
Pharmaceuticals: Generic
industry (222 stocks)
-6%
Poorly correlated
+2.50%